Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Operating Margin Over TimeStrong
Percentile Rank93
3Y CAGR+13.0%
5Y CAGR+1.6%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

3Y CAGR
+13.0%/yr
Annual compound
5Y CAGR
+1.6%/yr
Recent acceleration
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM58.45%+7.6%
202454.32%+33.4%
202340.71%+0.4%
202240.53%-34.9%
202162.24%+15.4%
202053.91%+256.3%
2019-34.50%+24.4%
2018-45.65%-278.4%
201725.58%+145.1%
2016-56.72%-